Artificial Intelligence in Cancer Care: Addressing Challenges and Health Equity.
Journal:
Oncology (Williston Park, N.Y.)
PMID:
40266052
Abstract
Overdiagnosis in cancer care remains a significant concern, often resulting in unnecessary physical, emotional, and financial burdens on patients. Artificial intelligence (AI) has the potential to address this challenge by enabling more accurate, personalized cancer diagnoses and facilitating tailored treatment plans. Integrating AI with precision medicine can minimize unnecessary treatments and associated adverse effects by optimizing care strategies based on individual patient data. However, the integration of AI in oncology requires rigorous research and validation to ensure its effectiveness across diverse populations and clinical settings. Challenges such as algorithmic bias, data representation, and limited access to technology in resource-constrained settings highlight the need for equitable AI applications in health care. Addressing health equity disparities is critical, as diverse and representative training data sets significantly affects the fairness and efficacy of AI systems. AI also holds promise for advancing cancer care in resource-limited settings by providing cost-effective diagnostic tools, democratizing access to advanced health care technologies, and improving outcomes in low- and middle-income nations. Interdisciplinary and international collaborations between researchers, clinicians, and technologists are crucial to maximizing AI's potential in cancer care. By fostering these partnerships and focusing on the development of accessible, ethical, and patient-centered AI applications, the health care community can revolutionize cancer diagnosis and treatment. The growing role of AI in precision medicine brings hope for equitable, cost-effective, and improved patient outcomes worldwide.